XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect of Change in Accounting Principles (See Note 2 - Recent Accounting Pronouncements)
Balance, January 1, 2020
Common Stock
Common Stock
Balance, January 1, 2020
Additional Paid-in Capital
Additional Paid-in Capital
Balance, January 1, 2020
Retained Earnings
Retained Earnings
Cumulative Effect of Change in Accounting Principles (See Note 2 - Recent Accounting Pronouncements)
Retained Earnings
Balance, January 1, 2020
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Balance, January 1, 2020
Beginning Balances (in shares) at Dec. 31, 2019       26,671,368 26,671,368              
Beginning Balances at Dec. 31, 2019 $ 573,820 $ (6,717) $ 567,103 $ 26,671 $ 26,671 $ 278,954 $ 278,954 $ 253,090 $ (6,717) $ 246,373 $ 15,105 $ 15,105
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 12,472             12,472        
Other Comprehensive Income (Loss) 13,255                   13,255  
Cash Dividends (5,065)             (5,065)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       41,752                
Restricted Share Grants 270     $ 42   228            
Stock Repurchase (in shares)       (173,089)                
Stock Repurchase (4,495)     $ (173)   (4,322)            
Ending Balances (in shares) at Mar. 31, 2020       26,540,031                
Ending Balances at Mar. 31, 2020 583,540     $ 26,540   274,860   253,780     28,360  
Beginning Balances (in shares) at Dec. 31, 2019       26,671,368 26,671,368              
Beginning Balances at Dec. 31, 2019 573,820 $ (6,717) $ 567,103 $ 26,671 $ 26,671 278,954 $ 278,954 253,090 $ (6,717) $ 246,373 15,105 $ 15,105
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 41,320                      
Other Comprehensive Income (Loss) 15,638                      
Ending Balances (in shares) at Sep. 30, 2020       26,492,866                
Ending Balances at Sep. 30, 2020 603,981     $ 26,493   274,166   272,579     30,743  
Beginning Balances (in shares) at Mar. 31, 2020       26,540,031                
Beginning Balances at Mar. 31, 2020 583,540     $ 26,540   274,860   253,780     28,360  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 14,255             14,255        
Other Comprehensive Income (Loss) 2,789                   2,789  
Cash Dividends (5,024)             (5,024)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       1,426                
Restricted Share Grants 282     $ 1   281            
Stock Repurchase (in shares)       (44,166)                
Stock Repurchase (1,168)     $ (44)   (1,124)            
Ending Balances (in shares) at Jun. 30, 2020       26,497,291                
Ending Balances at Jun. 30, 2020 594,674     $ 26,497   274,017   263,011     31,149  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 14,593             14,593        
Other Comprehensive Income (Loss) (406)                   (406)  
Cash Dividends (5,025)             (5,025)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       (378)                
Restricted Share Grants 254         254            
Stock Repurchase (in shares)       (4,047)                
Stock Repurchase (109)     $ (4)   (105)            
Ending Balances (in shares) at Sep. 30, 2020       26,492,866                
Ending Balances at Sep. 30, 2020 603,981     $ 26,493   274,166   272,579     30,743  
Beginning Balances (in shares) at Dec. 31, 2020       26,502,157                
Beginning Balances at Dec. 31, 2020 624,709     $ 26,502   274,385   288,447     35,375  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 19,557             19,557        
Other Comprehensive Income (Loss) (21,828)                   (21,828)  
Cash Dividends (5,554)             (5,554)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       44,123                
Restricted Share Grants 329     $ 44   285            
Ending Balances (in shares) at Mar. 31, 2021       26,546,280                
Ending Balances at Mar. 31, 2021 617,213     $ 26,546   274,670   302,450     13,547  
Beginning Balances (in shares) at Dec. 31, 2020       26,502,157                
Beginning Balances at Dec. 31, 2020 624,709     $ 26,502   274,385   288,447     35,375  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 64,865                      
Other Comprehensive Income (Loss) (24,111)                      
Ending Balances (in shares) at Sep. 30, 2021       26,546,100                
Ending Balances at Sep. 30, 2021 650,139     $ 26,546   275,682   336,647     11,264  
Beginning Balances (in shares) at Mar. 31, 2021       26,546,280                
Beginning Balances at Mar. 31, 2021 617,213     $ 26,546   274,670   302,450     13,547  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 23,822             23,822        
Other Comprehensive Income (Loss) 12,878                   12,878  
Cash Dividends (5,555)             (5,555)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       (576)                
Restricted Share Grants 639         639            
Ending Balances (in shares) at Jun. 30, 2021       26,545,704                
Ending Balances at Jun. 30, 2021 648,997     $ 26,546   275,309   320,717     26,425  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
NET INCOME 21,486             21,486        
Other Comprehensive Income (Loss) (15,161)                   (15,161)  
Cash Dividends (5,556)             (5,556)        
Issuance of Common Stock for:                        
Restricted Share Grants (in shares)       396                
Restricted Share Grants 373         373            
Ending Balances (in shares) at Sep. 30, 2021       26,546,100                
Ending Balances at Sep. 30, 2021 $ 650,139     $ 26,546   $ 275,682   $ 336,647     $ 11,264